London Area, United Kingdom
-3 decades of experience in developing and adapting strategy in fast paced growth company environments, leading change and organisational renewal to translate vision into execution to deliver results - Leading business development, corporate development and acceleration of growth in companies ranging from private tech start-ups, SMEs to growth ventures, midcap and LSE listed, international organisations - Building propositions, consortia & partnerships around e-mobility and distributed energy resources with a particular focus on EV smart charging (V1G) and vehicle-to-grid (V2G) services - Investment in and accelerating growth in VC/PE backed Technology & Life Sciences ventures - Turnaround management in Private Equity backed Technology & Business Services companies - Investment evaluation, commercial structuring, negotiation and management of investment, outsourcing, joint-venture and M&A transactions, organising equity/debt financing from venture capital and private equity investors
AkinovA provides a unique regulated, neutral, one-stop-shop electronic marketplace operating at the intersection between re/insurance and capital markets to transfer and trade insurance (insurance, reinsurance, Insurance-Linked-Securities) risks. AkinovA connects brokers with required capacity and investors with dealflow for uncorrelated returns.
Developing patented combinations of existing antibiotics and Antibiotic Resistance Breakers (ARBs) for treatment of multi-drug resistant (MDR) Gram-negative infections. Helperby’s ARBs can rejuvenate existing, but no longer effective, antibiotics killing dormant and multi drug resistant bacteria, across 5 out of 11 classes of anti-infectives investigated sofar. For more information see: www.helperby.com
Nuvve (NASDAQ: NVVE) is a world-leading Vehicle2Grid aggregator, turning EVs and stationary batteries into a virtual power plant, enabling behind-the-meter energy savings as well as revenue generation from energy market participation and service delivery to transmission and distribution system operators. Responsible for rollout of smart charging (V1G), vehicle-to-grid (V2G) and e-mobility services across Europe by developing propositions, commercial partnerships, consortia and sales channels with utilities, lease companies, EV OEMs, charge point operators (CPOs), car clubs, distribution network operators (DNOs), transmission system operators (TSOs), private and public clients.
Metellus is a venture capital firm specialising in early stage investments in technology and life sciences. The focus is on accelerating commercialisation of ground breaking innovation through investment, experienced hands-on management and intelligent partnering. www.metellus.ch Metellus is a member of SECA, the Swiss Private Equity & Corporate Finance Association.
Venture Capital & Interim Management for Technology & Life Sciences. Responsible for managing Metellus as well as performance of the portfolio of investments in Technology & Life Sciences businesses in US, UK, Switzerland & Sweden. Selection of portfolio: izettle.com (acquired by Paypal), QuantalRF.com (Dockon), Brandos.se (Footway), ImmuneRegulation.com (Peptinnovate), Helperby.com
Peptinnovate (now: Immune Regulation) is developing revolutionary disease modifying respiratory and anti-inflammatory medicines. First in class anti-inflammatory drugs for acute and chronic indications such as Asthma, COPD, Rheumatoid Arthritis, Reperfusion Injury following surgery, transplants, myocardial infarction or trauma. As potent as steroids, without the serious side effects. Phase I ready. Collaboration partnerships in place, further under discussion. For more information: www.immuneregulation.com